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Abstract
Purpose To prospectively evaluate the psychometric prop-
erties of the Venous Insufficiency Epidemiological and
Economic Study (VEINES-QOL/Sym) questionnaire, an
instrument to measure disease-specific quality of life and
symptoms in elderly patients with deep vein thrombosis
(DVT), and to validate a German version of the questionnaire.
Methods In a prospective multicenter cohort study of
patients aged C65 years with acute venous thromboem-
bolism, we used standard psychometric tests and criteria to
evaluate the reliability, validity, and responsiveness of the
VEINES-QOL/Sym in patients with acute symptomatic
DVT. We also performed an exploratory factor analysis.
Results Overall, 352 French- and German-speaking patients
were enrolled (response rate of 87 %). Both language versions
of the VEINES-QOL/Sym showed good acceptability (miss-
ing data, floor and ceiling effects), reliability (internal con-
sistency, item-total and inter-item correlations), validity
(convergent, discriminant, known-groups differences), and
responsiveness to clinical change over time in elderly patients
with DVT. The exploratory factor analysis of the VEINES-
QOL/Sym suggested three underlying dimensions: limitations
in daily activities, DVT-related symptoms, and psychological
impact.
Conclusions The VEINES-QOL/Sym questionnaire is a
practical, reliable, valid, and responsive instrument to
measure quality of life and symptoms in elderly patients
with DVT and can be used with confidence in prospective
studies to measure outcomes in such patients.
Keywords Health-related quality of life  Elderly
patients  Acute deep vein thrombosis  Disease-specific
quality of life questionnaire
Introduction
Acute deep vein thrombosis (DVT) is common and has a
high impact on morbidity, mortality, costs of care, and
quality of life [1, 2]. Besides the transient discomfort
related to acute DVT, health-related quality of life
(HRQoL) is substantially influenced by the development of
DVT-related complications, such as the post-thrombotic
syndrome (PTS) [3].
Although the incidence rate of DVT increases markedly
with advancing age [4], no study has evaluated HRQoL in
elderly patients with DVT. In fact, few studies reported on
HRQoL after DVT and most of them were limited by
retrospective design [5] and the absence of a disease-spe-
cific HRQoL measure [6], or enrolled younger patients
with DVT [2]. Given the reduced life expectancy and the
observation that baseline HRQoL tends to be lower in older
patients [7], HRQoL aspects may be particularly relevant in
the elderly with DVT.
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Assessment of HRQoL should ideally include both a
generic and a disease-specific instrument allowing outcome
evaluation of patients with the same disease. The Venous
Insufficiency Epidemiological and Economic Study (VE-
INES-QOL/Sym) questionnaire, developed to assess
HRQoL in patients with venous disease, was shown to be
acceptable, reliable, valid, and responsive for use in
patients with DVT [8, 9]. However, given that the VE-
INES-QOL/Sym was developed and validated in younger
patients only (mean age 46–56 years) [8, 9], we aimed to
prospectively evaluate the psychometric properties of the
VEINES-QOL/Sym questionnaire in a Swiss cohort of
elderly patients with DVT. Our second objective was to
prospectively validate the psychometric properties of a
German version of the VEINES-QOL/Sym questionnaire.
Methods
VEINES-QOL/Sym questionnaire
The VEINES-QOL/Sym questionnaire is a 26-item ques-
tionnaire designed for self-completion [8]. It measures the
impact of DVT on symptoms and HRQoL from the
patient’s perspective. The questionnaire covers DVT-rela-
ted symptoms (10 items), limitations in daily activities (9
items), psychological impact (5 items), the amount of
change in the respondent’s leg problem over the past year
(1 item), and the time of day that the leg problem is most
intense (1 item). As in the widely known Short-Form
Health Survey (SF-36), the time frame for questions about
symptoms, limitations in daily activities, and psychological
impact covers the previous 4 weeks [10]. Responses are
rated on a Likert response scale.
To date, there exist English, French, Norwegian, Dutch,
Turkish, and Italian language versions of the VEINES-
QOL/Sym questionnaire [9, 11–13], but only the English,
French, and Norwegian versions were validated for use in
patients with acute DVT [8, 11]. Because no German
version of this questionnaire was available, we performed a
forward and backward translation from the original English
version of the VEINES-QOL/Sym questionnaire into
German according to previously published methods [14].
In a first step, two independent native German speakers, of
whom one was a translator with no medical background,
performed a forward translation from the original English
version into German. In a second step, two naı¨ve English
speakers performed a backward translation into English. A
committee of three experts reviewed all translations and
reached a consensus on any discrepancy. The final German
version is shown in the supplemental online appendix.
Scoring the VEINES-QOL/Sym
Of the 26 items in the questionnaire, 25 are summed to
create the VEINES-QOL summary score, which provides
an estimate of the respondent’s HRQoL related to the
overall impact of DVT on patient’s quality of life [8, 9]. A
subset of 10 items is summed to create a separate summary
score measuring symptom severity, the VEINES-Sym
score. It includes nine venous symptoms (heavy legs,
aching legs, swelling, night cramps, heat or burning sen-
sation, restless legs, throbbing, itching, and tingling sen-
sation), rated on a 5-point scale of frequency, and leg pain,
rated on a 6-point scale of intensity. The scales of items 3,
6, and 7 are reversed, a higher score indicating a better
outcomes. One item (question 2), ‘At what time of day is
your leg problem most intense,’ provides only descriptive
information and is not scored. Item 4a was considered
missing if the answer was ‘I do not work.’ For both the
VEINES-QOL and VEINES-Sym scales, higher scores
indicate better outcomes [8, 9].
As described in the initial VEINES-QOL/Sym publica-
tions [8, 9], we used the standard method for scoring
questionnaires comprising items with different response
scales [15]. Raw scores were first transformed to z-scores
(mean 0; standard deviation 1) and then were averaged to
form summary scores, in case where the patient answered
at least 50 % of the items in the summary scores. Finally,
the mean z-scores were transformed to T-scores (mean 50;
standard deviation 10).
Validation of the VEINES-QOL/Sym in the Swiss
cohort of elderly patients with venous
thromboembolism (SWITCO65?)
SWITCO65? is an ongoing prospective multicenter
cohort study to assess long-term medical outcomes and
HRQoL in consecutive inpatient and outpatient
aged C 65 years with acute venous thromboembolism
(VTE) from all five university and four high-volume non-
university hospitals in Switzerland [16]. For this project,
we only considered patients with objectively confirmed,
acute symptomatic DVT. Symptomatic DVT was defined
as an acute onset of leg pain or swelling plus incomplete
compressibility of a venous segment on ultrasonography
or an intraluminal filling defect on contrast venography. A
detailed description of the study methods, including the
detailed definition of DVT and inclusion and exclusion
criteria, was previously published [16]. The study was
approved by the Institutional Review Board at each par-
ticipating center.
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Data collection
For all enrolled patients, trained study nurses prospectively
collected baseline demographic information, comorbid
conditions, laboratory findings, and VTE-related treatment,
using standardized data collection forms. Follow-up
included face-to-face evaluations at 3, 12, and 24 months.
At each visit, patient-reported symptoms and HRQoL were
assessed using the appropriate language versions (i.e.,
French or German) of the VEINES-QOL/Sym and SF-36
questionnaires. If patients were unable to self-complete the
questionnaires, they were assisted by the study nurse. The
decision to assist was left to the study nurse’s discretion.
The SF-36 questionnaire is a generic HRQoL measure
containing eight scales (physical functioning, social func-
tioning, physical role functioning, emotional role func-
tioning, mental health, vitality, bodily pain, and general
health), scoring 0–100, with higher values indicating better
health [10, 17]. Combining scales into a physical health
summary (PCS) score and mental health summary (MCS)
score creates two summary scores. Standardized dimension
and summary scores of the SF-36 questionnaire were cal-
culated using the US 1998 reference population [18].
At each visit, symptoms and signs of the PTS were
assessed by a study nurse using a validated clinical scale
developed by Villalta et al. [19]. This scale grades the
severity, from 0 (absent) to 3 (severe), of each of five
symptoms (pain, cramps, heaviness, pruritus, and pares-
thesia) and six signs (edema, skin induration, hyperpig-
mentation, venous ectasia, redness, and pain during calf
compression). The maximum score is 33. A score of C5 or
the presence of a venous ulcer is indicative of the PTS. The
Villalta scale classifies patients with PTS into three
severity categories: mild (5–9 score points), moderate
(9–14 score points), and severe ([14 score points or pre-
sence of a venous ulcer).
Psychometric evaluation of the VEINES-QOL/Sym
questionnaire
We used standard psychometric tests and criteria to eval-
uate the acceptability, reliability, validity, and responsive-
ness of the VEINES-QOL/Sym using questionnaires filled
in at 3 months after the acute DVT because the time frame
for questions in the HRQoL measures covers the preceding
4 weeks [8, 9, 20]. Hence, scores at baseline (i.e., at the
time of presentation with acute DVT) would reflect a
composite of pre-DVT-related and acute DVT-related
HRQoL.
The study sample was divided into two groups accord-
ing to the language version of the VEINES-QOL/Sym
questionnaire, French and German. Baseline characteristics
were shown as number and percentage or median and
interquartile range (IQR), as appropriate. The transformed
VEINES-QOL/Sym summary scores were depicted in a
box plot as medians with interquartile ranges (IQRs) and
whiskers with maximum length of 1.5 IQRs. Associations
between patient characteristics and one or more missing
items per patient were assessed by the chi-squared test and
Wilcoxon rank-sum test as appropriate.
Acceptability affects the quality of the data obtained and
was assessed by examining completeness of data and score
distribution. To assess floor and ceiling effects, the pro-
portion of patients achieving the lowest or highest possible
score per summary score was calculated. Criteria for a
good acceptability included\5 % missing data and\15 %
floor and ceiling effects for summary scores [20].
We assessed reliability by measuring internal consis-
tency, which was measured by Cronbach’s alpha, average
inter-item correlation, and item-total correlation. Internal
consistency refers to the extent to which items comprising
the score measure the same construct (i.e., homogeneity of
the score) and was considered acceptable when Cronbach’s
alpha was[0.7. We regarded an item-total correlation[0.2
and an average inter-item correlation [0.3 as good [20].
Factor analysis is widely used to evaluate whether
questionnaire items can be grouped into clusters repre-
senting different dimensions of the construct under study
[21]. We performed an exploratory factor analysis with
orthogonal varimax rotation on the items of both language
versions of the VEINES-QOL/Sym questionnaires. The
number of retained factors was determined by a scree test.
Question 4a (‘Does your leg problem now limit you in
daily activities at work?’) was omitted from the factor
analysis because most patients in our sample did not work.
An item was considered to load on a given factor if the
loading was [0.3 for this factor.
Construct validity refers to the extent to which VEINES-
QOL/Sym summary scores relate to other measures in a
manner consistent with theoretically derived hypotheses
[20, 22]. We first evaluated construct validity by calculating
pairwise Spearman’s correlations between VEINES-QOL/
Sym and SF-36 summary scores (convergent validity).
Because both questionnaires assess HRQoL, we assumed
that the two measures would be correlated in a moderate
range, one being a disease-specific and the other a generic
HRQoL questionnaire. We then evaluated correlations
between VEINES-QOL/Sym summary scores and clinical
characteristics (discriminant validity). Our hypothesis was
that correlation with age, gender, and the presence of a
concomitant comorbid condition would be low. Known-
groups differences validity was assessed by presenting the
median and IQR of the VEINES summary scores by
severity of the PTS based on the Villalta scale. We expected
that the VEINES-QOL/Sym scores (i.e., quality of life)
would decrease with increasing severity of the PTS.
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To evaluate the responsiveness of the VEINES-QOL/
Sym questionnaire, we tested the ability of the VEINES-
QOL/Sym to detect clinically important change over time
by comparing mean changes in VEINES-QOL/Sym scores
between three and 12 months after the acute DVT in
patients with and without clinical improvement. Clinical
improvement was defined as a decrease in DVT-related
pain and severity of PTS based on the Villalta scale.
To validate the German version of the VEINES-QOL/
Sym questionnaire, we compared its psychometric prop-
erties with those of the French version, which has already
been shown to be acceptable, reliable, valid, and responsive
in patients with DVT [8, 9].
Results
Study sample
From September 2009 to March 2012, 446 patients with
acute DVT were enrolled in SWITCO65? (Fig. 1). After
3 months of follow-up, 23 patients were dead, 12 had
withdrawn informed consent, and five were lost to follow-
up. Of the 406 remaining patients, 54 did not fill in the
questionnaires, leaving a final study sample of 352
responders (response rate 87 %). Responders had a median
age of 74 years, 161 (46 %) were female, 269 (76 %) were
not working, and 57 (16 %) had an active cancer. Overall,
107 (30 %) were French speakers, and 245 (70 %) were
German speakers. French speakers were somewhat older
and had more comorbid illnesses than German-speaking
patients (Table 1). Non-responders were older than
responders (median age 78 vs. 74 years; P = 0.02) and
were more likely to have a concomitant overt pulmonary
embolism (54 vs. 27 %; P \ 0.001).
Psychometric properties of the VEINES-QOL/Sym
The median-transformed VEINES-QOL and VEINES-Sym
summary scores were 48.5 (IQR 36.8–56.6) and 50.4 (IQR
40.2–56.8) in the French-speaking sample and 54.4 (IQR
46.2–59.1) and 53.9 (IQR 47.4–58.7) in the German-
speaking sample, respectively.
Acceptability
Both language versions showed good acceptability, with
low proportions of missing data and floor/ceiling effects
(Table 2). Overall, 12 % of patients had C1 missing items.
Missing items ranged between 2 and 9 % in the French-
speaking sample and 0 and 1 % in the German-speaking
sample. French speakers were more likely to have one or
446 Patients with DVT enrolled
54 HRQoL questionnaires not filled in
245 German-speaking sample
40 Patients excluded
12 Informed consent withdrawn
23 Patients died
5 Patients lost to follow-up
352 Analyzed HRQoL 
107 French-speaking sample
20 Patients excluded at 12 months
7 Patients died
13 HRQoL questionnaires not filled in
39 Patients excluded at 12 months
3 Informed consent withdrawn
9 Patients died
1 Patients lost to follow-up
26 HRQoL questionnaires not filled in
Fig. 1 Flowchart. DVT deep vein
thrombosis, HRQoL health-related quality of
life
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more missing items than German speakers (28 vs. 4 %;
P \ 0.001), and women had more missing items than men
(17 vs. 7 %; P = 0.006). Age was not associated with
missingness.
Factor analysis
The factor analyses suggested three underlying latent fac-
tors (dimensions) for both questionnaires: limitations in
daily activities (items 4b–d, 5a–d, 6, and 7), DVT-related
symptoms (items 1a–i), and psychological impact (items
8a–e). Item 3 (‘Compared to 1 year ago, how would you
rate your leg problem in general now?’) did not load on any
factor (loadings B0.3), indicating that it could be omitted
from the VEINES-QOL summary score. The detailed fac-
tor analyses are shown in the supplemental online
appendix.
Internal consistency reliability
Cronbach’s alpha coefficients were [0.8 in both language
versions, indicating high internal consistency (Table 2)
[20]. Items were positively correlated with each other, with
average inter-item correlations of [0.3 (Table 2). Almost
all item-total correlation values were [0.2, ranging from
0.42 to 0.79 for the French-speaking sample and from 0.35
to 0.80 for the German-speaking sample [20]. Only item 3,
asking: ‘Compared to 1 year ago, how would you rate your
leg problem in general now?’, was not correlated with
other items (item-total correlation of 0.18 and -0.10,
respectively), suggesting again that this item could be
omitted from the VEINES-QOL summary score. Ceiling
and floor statistics, Cronbach’s alpha, and item-score cor-
relations for each individual item are shown in the sup-
plemental online appendix.
Construct validity (convergent, discriminant, and known-
groups differences validity)
We did a correlation analysis using SF-36 component
scores to assess convergent validity of the VEINES-QOL/
Sym summary scores (Table 3). In both language versions,
the VEINES-QOL/Sym was moderately correlated with
SF-36 summary scores and showed higher correlations for
the PCS than for the MCS. In general, the VEINES-QOL
summary scores showed a better correlation with the SF-36
summary scores than the VEINES/Sym summary scores.
Age, gender, and the presence of a concomitant comorbid
condition were very weakly correlated with VEINES-QOL
and VEINES/Sym summary scores (r \ 0.19) in both
language versions, indicating a good discriminant validity.
This suggests that responses to the VEINES-QOL/Sym are
not biased in terms of age, gender, or a concomitant
comorbid condition (Table 3).
In both language versions, the VEINES-QOL/Sym
summary scores demonstrated lower scores (i.e., poorer
QOL) with increasing severity of PTS, demonstrating that
Table 1 Patient characteristics
French-
speaking
sample
(N = 107)
German-
speaking
sample
(N = 245)
Median (IQR) or n (%)
Age (years) 76 (68–80) 74 (69–80)
Female gender 53 (50) 108 (44)
Less than high school as highest
educational level
55 (51) 133 (54)
Not working 77 (72) 192 (78)
Living in nursing home 0 (0) 6 (2)
Prior venous thromboembolism 41 (38) 73 (30)
Outpatient 52 (49) 94 (38)
Overt pulmonary embolism 28 (26) 68 (28)
Active cancer 22 (21) 35 (14)
Cardiac disease 19 (18) 48 (20)
Chronic lung disease 12 (11) 24 (10)
Cerebrovascular disease 4 (4) 19 (8)
Diabetes mellitus 22 (21) 34 (14)
Villalta scorea 5 (3–8) 4 (2–6)
IQR interquartile range
a At 3 months after the index venous thromboembolic event
Table 2 Acceptability and internal consistency reliability of the
VEINES-QOL/Sym
French-speaking
sample
(N = 107)
German-speaking
sample
(N = 245)
Scorable questionnairesa (%)
VEINES-QOL 100 100
VEINES-Sym 96 100
Floor effects (%)
VEINES-QOL 0 0
VEINES-Sym 0 0
Ceiling effects (%)
VEINES-QOL 0 0.4
VEINES-Sym 7.8 12.2
Cronbach’s alpha
VEINES-QOL 0.93 0.92
VEINES-Sym 0.88 0.82
Average inter-item correlation, r
VEINES-QOL 0.34 0.31
VEINES-Sym 0.43 0.32
a Defined as 50 % or more of items completed
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known-groups differences validity was good (Table 4). In
summary, all correlations supported our hypotheses and
confirmed the construct validity of the VEINES-QOL/Sym
questionnaire in elderly patients with DVT.
Responsiveness
After 12 months, 293 out of 332 (88 %) patients who
attended the follow-up visit completed the questionnaires
and were available for our responsiveness analysis. In this
analysis, we compared the summary score changes of the
VEINES-QOL/Sym questionnaire between three and
12 months after the acute DVT in patients with and without
a clinical improvement with respect to DVT-related pain
and severity of the PTS (Table 5). In the German ques-
tionnaire, the VEINES-QOL and VEINES/Sym summary
scores were both significantly responsive to clinical
change. Differences in mean change scores between
patients with clinical improvement and patients without
clinical improvement ranged between 4.9 and 2.2 points
(P values B0.04 for all comparisons).
In the French questionnaire, we measured a larger change
in VEINES-QOL and VEINES/Sym scores in patients who
had clinically improved. Differences in mean change scores
between patients with clinical improvement and patients
without clinical improvement ranged between 4.9 and 0.7
points. However, the difference in change only achieved
statistical significance for the VEINES-QOL score when
comparing patients with and without improvement of DVT-
related pain (P = 0.02).
Discussion
Our results demonstrate that both the French and German
versions of the VEINES-QOL/Sym questionnaire meet
standard criteria of acceptability, reliability, validity, and
responsiveness for use as a patient-reported measure of
outcome in elderly patients with acute DVT. A number of
other disease-specific quality of life instruments intended
for use in patients with DVT have been proposed, but none
has been validated in elderly patients [23–25]. Thus,
although the VEINES-QOL/Sym was developed and vali-
dated in younger patients (mean age 46–56 years) [8, 9, 11],
it can also be applied with confidence to elderly patients.
In this sample of elderly patients with acute DVT, the
response rate was 87 % 3 months after the acute DVT
event. Our response rate compares well to studies enrolling
younger patients in whom the response rates for the VE-
INES-QOL/Sym ranged from 72 to 100 % [8, 11, 12]. In
our study, although assistance was offered to patients who
Table 3 Convergent and discriminant validity of the VEINES-QOL/
Sym
French-speaking sample
(N = 107)
German-speaking
sample (N = 245)
VEINES-
QOL
VEINES-
Sym
VEINES-
QOL
VEINES-
Sym
SF-36
PCS 0.72* 0.52* 0.62* 0.45*
MCS 0.66* 0.51* 0.44* 0.32*
Patient characteristics
Age -0.04 0.07 -0.14 -0.14
Female
gender
-0.16 -0.12 -0.19 -0.14
Comorbidity -0.05 -0.04 -0.07 -0.02
Active cancer -0.11 -0.01 -0.09 -0.02
PCS physical health summary score, MCS mental health summary
score
* P \ 0.001
 P \ 0.05
 Presence of cardiac, cerebrovascular, or chronic lung disease, or
diabetes mellitus
Table 4 Known-groups differences validity of the VEINES-QOL/Sym*
French-speaking sample (N = 107) German-speaking sample (N = 245)
N VEINES-QOL score,
median (IQR)
VEINES-Sym score,
median (IQR)
N VEINES-QOL score,
median (IQR)
VEINES-Sym score,
median (IQR)
Overall 107 48.5 (36.8–56.6) 50.4 (40.2–56.8) 232 54.3 (46.2–59.1) 53.9 (47.4–58.8)
No PTS 47 50.1 (42.0–57.5) 52.2 (45.2–58.7) 130 57.2 (50.2–60.5) 57.4 (51.5–60.5)
Mild PTS 43 48.7 (36.0–56.6) 50.4 (41.8–57.5) 77 52.3 (45.4–57.1) 50.8 (45.0–54.6)
Moderate PTS 8 36.3 (28.7–52.4) 37.9 (32.0–55.0) 16 39.0 (33.3–50.7) 42.4 (30.2–49.8)
Severe PTS 9 36.5 (30.8–43.3) 37.3 (27.4–47.4) 9 37.7 (36.3–38.9) 39.1 (36.3–45.8)
P value – 0.003 0.02 – \0.001 \0.001
*Expressed as median VEINES-QOL/Sym scores by severity of the PTS based on the Villalta scale [19]
IQR interquartile range, PTS post-thrombotic syndrome
 P value for difference between PTS-groups based on a Kruskal–Wallis test
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were unable to self-complete the questionnaires, 13 % of
patients who attended the follow-up visit at 3 months did
not complete the questionnaires. The reason may be that
non-responders were significantly older and sicker than
responders. Previous studies validating the use of the SF-36
in older adults found that non-completion was associated
with increasing age and that persons with poor physical and
mental health scores felt more often unable to self-com-
plete the SF-36 and required assistance [7, 26]. The fact
that patients were required to complete a total of three
HRQoL questionnaires (SF-36, VEINES-QOL/Sym, and a
pulmonary-embolism-related HRQoL questionnaire) in
SWITCO65? may also have reduced the response rate. A
high questionnaire burden was previously shown to be an
obstacle to study participation and adherence in elderly
patients and should be minimized when designing studies
focusing on the elderly [27].
In our sample of elderly patients with DVT, the
exploratory factor analysis supported the formation of three
dimensions [limitations in daily activities, (items 4, 5, 6,
and 7); DVT-related symptoms, (item 1); and psychologi-
cal impact, (item 8)]. Question 3 (‘Compared to 1 year ago,
how would you rate your leg problem in general now?’) did
not load on any factor and was not correlated with other
items, indicating that it could be omitted without loss of
information in elderly patients with acute DVT. This
finding is consistent with the results from a previous vali-
dation study of patients with chronic venous disease, in
which question 3 did not sufficiently load on the factor in a
confirmatory factor analysis [12]. Moreover, when
answering question 4a (‘Does your leg problem now limit
you in daily activities at work’), three quarter of our
patients responded ‘I do not work’, presumably, because
the majority of persons aged over 65 years are retired. This
suggests that this question may not be relevant and could
be omitted in elderly patients. Finally, to shorten the time
required to complete the VEINES-QOL/Sym, question 2
(‘At what time of day is your leg problem most intense’)
could also be omitted because it provides only descriptive
information and is not scored. The omission of these three
questions has the potential to make the VEINES-QOL/Sym
questionnaire more user friendly for elderly patients and
may further increase the response rate. However, the val-
idation of such a VEINES-QOL/Sym version for the
elderly is required before its use can be recommended.
Compared to German-speaking patients, French-speak-
ing patients were somewhat older and more likely to suffer
from prior venous thromboembolism, active cancer, and
diabetes mellitus, which could explain the lower median
VEINES-QOL/Sym scores and higher rate of missing items
in the French-speaking sample.
Our study has potential limitations. First, we were not
able to assess test–retest reliability of the VEINES-QOL/
Sym, which is an indicator of the stability of a measuring
instrument. Previous studies enrolling younger patients
found a good test–retest reliability (intraclass correlation
coefficients of[0.8) for the VEINES-QOL/Sym in patients
with DVT [8, 11]. Second, the German version of the
VEINES-QOL/Sym questionnaire met standard criteria of
acceptability, reliability, validity, and responsiveness for
use in elderly patients with acute DVT, but it needs to be
validated in younger patients before its use can be rec-
ommended in such patients. Third, this sample may not
reflect the full prognostic spectrum of patients with acute
DVT because responders were younger and healthier than
non-responders. Thus, we cannot exclude the possibility
Table 5 Responsiveness of the VEINES-QOL/Sym
French-speaking sample (N = 87) German-speaking sample (N = 206)
Clinically*
improved
Clinically*
unimproved
P value§ Clinically*
improved
Clinically*
unimproved
P value§
Mean change
scores (n)
Mean change
scores (n)
Deep vein thrombosis-related pain
VEINES-QOL 4.9 (10) 0.0 (77) 0.02 3.4 (32) 0.2 (171) 0.02
VEINES-Sym 3.5 (9) 0.3 (74) 0.17 4.2 (32) -0.7 (171) 0.002
Severity of post-thrombotic syndrome
VEINES-QOL 1.0 (38) 0.3 (49) 0.59 2.1 (89) -0.1 (108) 0.03
VEINES-Sym 1.3 (37) 0.0 (46) 0.37 1.4 (89) -1.0 (108) 0.04
* Clinical improvement is defined as a decrease in deep vein thrombosis-related pain or severity of the post-thrombotic syndrome based on the
Villalta scale [19]
 Expressed as mean change in scores between three and 12 months following deep vein thrombosis
 Number of patients in whom the mean change scores could be calculated. The numbers vary depending on reporting of deep vein thrombosis-
related pain and the PTS, and the completion rate of the VEINES-QOL/Sym at 12 months
§ P value comparing the mean change in VEINES-QOL/Sym summary scores between patients with and without clinical improvement
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that our results would differ in more severe ill patients.
Finally, we did not ascertain the proportion of patients who
needed assistance to complete the questionnaires. Thus, we
would expect a higher proportion of non-responders and
missing items if the questionnaires were based on self-
completion only.
In conclusion, our results demonstrate that the VEINES-
QOL/Sym is a practical, reliable, valid, and responsive
instrument to measure DVT-specific HRQoL in elderly
patients. Thus, disease-specific quality of life and symptom
assessment based on the VEINES-QOL/Sym can be
incorporated with confidence in prospective studies of
elderly patients with acute DVT.
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